Biotage
Stock
Stock
ISIN: SE0000454746
Ticker: BIOT
SE0000454746
BIOT
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 02.05.2025
$0.114
CHART BY
Frequently asked questions
What is Biotage's market capitalization?
The market capitalization of Biotage is $1.17B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Biotage's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Biotage is 44.15. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Biotage?
Biotage's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.333. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Biotage's stock?
Currently, 3 analysts cover Biotage's stock, with a consensus target price of $14.53. Analyst ratings provide insights into the stock's expected performance.
What is Biotage's revenue over the trailing twelve months?
Over the trailing twelve months, Biotage reported a revenue of $204.45M.
Is Biotage paying dividends?
Yes, Biotage is paying dividends. The next payment is scheduled for 02.05.2025, with an expected amount of .
What is the EBITDA for Biotage?
Biotage's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $48.69M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Biotage?
Biotage has a free cash flow of $27.52M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Biotage have, and what sector and industry does it belong to?
Biotage employs approximately 673 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Biotage's shares?
The free float of Biotage is 65.39M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.17B
- EPS (TTM)
- $0.333
- Free Float
- 65.39M
- P/E ratio (TTM)
- 44.15
- Revenue (TTM)
- $204.45M
- EBITDA (TTM)
- $48.69M
- Free Cashflow (TTM)
- $27.52M
Pricing
- 1D span
- $14.56$14.86
- 52W span
- $8.097$19.62
Analyst Ratings
The price target is $14.53 and the stock is covered by 3 analysts.
Buy
2
Hold
1
Sell
0
Information
Biotage AB engages in the provision of separation and synthesis technology solutions. Its products and services include sample preparation, horizon food and environmental products, organic synthesis, peptide chemistry, flash purification, work-up products, evaporation and concentration, and service and support. The company was founded by Pal Nyren, Carl Erik Mathias Uhlen, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Bjorn Ekstrom in 1969 and is headquartered in Uppsala, Sweden.
- Employees
- 673
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0000454746
- Primary Ticker
- BIOT
Knockouts
LSX Data · Fundamentals & EOD data from FactSet